Skip to search formSkip to main contentSkip to account menu

Pentasa

National Institutes of Health

Related topics

Related topics

6 relations

Narrower (1)

5-Aminosalicylate

Broader (3)

Anti-Inflammatory Agents, Non-Steroidalaminosalicylic acidmesalamine
Asacolmesalamine Enema [Rowasa]

Papers overview

Semantic Scholar uses AI to extract papers important to this topic.
2012
2012
Tu1228 Disparity in Clinical Care for Patients With Inflammatory Bowel Disease Between Specialists and Non-Specialists
2008
2008
New Dissolution Method for Mesalamine Tablets and Capsules
Dissolution methods are different for extended-release mesalamine capsules (pH 7.5 only) and delayed-release tablets (pH 1.4, 6.0… 
2003
2003
Efficacy of Pentasa tablets for the treatment of inflammatory bowel disease.
BACKGROUND AND PURPOSE The Eudragit S formulation of delayed-release 5-aminosalicylic acid (5-ASA), Asacol tablets (AT), has… 
2000
2000
Gastrointestinal spread of oral prolonged‐release mesalazine microgranules (Pentasa) dosed as either tablets or sachet
: There is increasing interest in using higher dosages of mesalazine for the treatment of inflammatory bowel disease; however… 
Review
2000
Review
2000
5-Aminosalicylic acid containing drugs. Delivery, fate, and possible clinical implications in man.
Since the beginning of the 1940s salazosulfapyridine (SASP) has been used in the treatment of chronic inflammatory bowel disease… 
1997
1997
Maladie de Crohn cutanée métastatique. À propos d'une observation
Highly Cited
1993
Highly Cited
1993
Oral mesalamine (Pentasa) as maintenance treatment in Crohn's disease: a multicenter placebo-controlled study. The Groupe d'Etudes Thérapeutiques des Affections Inflammatoires Digestives (GETAID)
1992
1992
[Efficacy of a daily application of mesalazine (Pentasa) suppository with progressive release, in the treatment of ulcerative proctitis. A double-blind versus placebo randomized trial].
Therapeutic efficacy of mesalazine controlled-release suppository 1 g once daily was compared with that of a placebo during 2… 
1992
1992
Disposition of mesalazine from mesalazine-delivering drugs in patients with inflammatory bowel disease, with and without diarrhoea.
The disposition of mesalazine from the azo compounds sulphasalazine and olsalazine (Dipentum) and from the slow-release… 
Highly Cited
1990
Highly Cited
1990
Slow-release 5-amino-salicylic acid (Pentasa) for the treatment of active Crohn's disease.
A double-blind, placebo-controlled trial of a slow-release preparation of 5-amino-salicylic acid (Pentasa) has been performed in… 
By clicking accept or continuing to use the site, you agree to the terms outlined in our Privacy Policy (opens in a new tab), Terms of Service (opens in a new tab), and Dataset License (opens in a new tab)